Tetra Bio Pharma Inc (TBPMQ)

[bigmoneyyyyyyyyy]

Tetra Bio-Pharma set to launch Phase 3 trial for cancer drug

Stockhouse Editorial

0 Comments| 52 minutes ago

Tetra Bio-Pharma Inc. (TSX: V.TBP, OTCQB: GRPOF, Forum) said Monday it has received Health Canada Phase 3 Clinical Trial Approval for its PPP001 Smokable Dried Cannabis Prescription Drug.

Coinciding with World Cancer Day 2018, Tetra is now ready to initiate Phase 3 clinical train for PPP001 in terminal cancer patients.

More information can be found here.

Tetra is a world leader in the drug development field of cannabis-based medications and is paving the road to become the first company to commercialize a dried marijuana product as a drug in North America.

The Ontario-based company was in the news recently when it and and Aphria Inc. (TSX: V.APH, OTCQB: APHQF, Forum) announced plans for the joint distribution of dried medical cannabis in the maritime provinces and Quebec.


Read more at http://www.stockhouse.com/news/newswire/2018/02/05/tetra-bio-pharma-set-to-launch-phase-3-trial-for-cancer-drug#s8hy1vacDbjBUpdc.99